Selected article for: "immune system and nitric oxide"

Author: Mir, Jan Mohammad; Maurya, Ram Charitra
Title: Nitric oxide boosters as defensive agents against COVID-19 infection: an opinion
  • Cord-id: gt2v4xhs
  • Document date: 2020_11_30
  • ID: gt2v4xhs
    Snippet: In the prevailing covid times, scientific community is busy in developing vaccine against COVID-19. Under such fascination this article describes the possible role of nitric oxide (NO) releasers in aiding the immune system of a human body against this dreadful pandemic disease. Despite some prodrug antiviral compounds are in practice to recover the patients suffering from covid-19, however, co-morbidity deaths are highest among the total deaths happened so far. This concurrence of a number of di
    Document: In the prevailing covid times, scientific community is busy in developing vaccine against COVID-19. Under such fascination this article describes the possible role of nitric oxide (NO) releasers in aiding the immune system of a human body against this dreadful pandemic disease. Despite some prodrug antiviral compounds are in practice to recover the patients suffering from covid-19, however, co-morbidity deaths are highest among the total deaths happened so far. This concurrence of a number of diseases in a patient along with this viral infection is indicative of the poor immunity. Literature background supports the use of NO as immunity boosting agent and hence, the nitric oxide releasing compounds could act as lucrative in this context. Some dietary suggestions of NO-containing food items have also been introduced in this article. Also, the profound effect of NO in relieving symptomatic severity of covid-19 has been opined in this work. Communicated by Ramaswamy H. Sarma

    Search related documents:
    Co phrase search for related documents
    • acute sars respiratory syndrome corona virus and low molecular weight: 1
    • acute sars respiratory syndrome corona virus and lung tissue: 1
    • additional condition and low density: 1
    • additional condition and low density lipoprotein: 1
    • lockdown strategy and long duration: 1